In summary, our study demonstrates that CD151 and its associated α3 integrin are markedly elevated in malignant gliomas, and synergize with EGFR-dependent signaling pathways to drive the aggressive behaviors of glioblastoma cells. The gene discussed is EGFR; the disease is malignant glioma.